ScanStation - Faster, Automated Plate Counting for Industry

Associates of Cape Cod, Inc. Receives FDA Approval to Manufacture at New Facility

Associates of Cape Cod, Inc. (ACC), the leading manufacturer of endotoxin and beta-glucan detection products and a major supplier to the pharmaceutical and medical device industries, today announced that the U.S. Food and Drug Administration (FDA) has granted approval to manufacture two of the Company's most prominent products at its new Falmouth Technology Park facility.

These two products, Pyrotell(R) 5 mL gel-clot reagent and Pyrotell-T(R) turbidimetric reagent, are used for release testing of injectable drugs, biologicals and medical devices for bacterial endotoxin contamination.

The Company's new state-of-the-art facility is designed specifically for the manufacture of Horseshoe Crab blood extract, or Limulus Amebocyte Lysate (LAL), reagents and associated products.

Submission for the approval of manufacturing of ACC's other licensed products at the new facility will be proposed to the FDA shortly.


NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source: Associates of Cape Cod, Inc. View latest company information

Posted: March 30, 2004
Request Information
[will open your email client]

© 2001 - 2017 Rapid Test Methods Ltd • Please join us on Twitter, Facebook and LinkedIn • RSS Feed